BUY Aurobindo Pharma — Swati Hotkar, Nirmal Bang Securities
bySwati Hotkar, Nirmal Bang SecuritiesHorizon: 1–3 months18 Aug 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Aurobindo Pharma's subsidiary, Lannett Company LLC, has launched a generic version of Advair Diskus® in the US. This product is used to treat asthma and COPD.
NSE · Press Release·31 Aug · today
Aurobindo Pharma's subsidiary, Lannett Company LLC, has launched a generic version of Advair Diskus in the US. This marks the first product from Aurobindo's inhalation pipeline to be commercialized in
BSE · Company Update·31 Aug · today
7 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·31 Aug · today
Aurobindo Pharma Share Price Gains As USFDA Concludes Inspection At Subsidiary Lannett's Unit
NewsNdtv-Profit·24 Aug · 1w ago
Aurobindo Pharma US FDA inspection ends with one observation at AuroPeptides facility
NewsCnbc-Tv18·21 Aug · 1w ago
Aurobindo Pharma’s API plant gets three US FDA observations after inspection
NewsCnbc-Tv18·28 Aug · 2d ago
Here's why these four pharma stocks are in focus today
NewsCnbc-Tv18·24 Aug · 1w ago
Aurobindo Pharma has announced its unaudited financial results for the first quarter ended June 30, 2026. The company has provided a press release detailing these results.
NSE · Press Release·5 Aug · 4w ago
Aurobindo Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·5 Aug · 4w ago
USFDA Issues Three Observations To Aurobindo Pharma Arm's Facility In Andhra
NewsNdtv-Profit·28 Aug · 2d ago
Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDA
NewsLivemint·24 Aug · 1w ago
Aurobindo Pharma shares in focus after USFDA closes Raleigh unit inspection with 11 observations
NewsCnbc-Tv18·17 Aug · 2w ago
Aurobindo Pharma shares fall after USFDA issues warning letter to Eugia's Unit 1
NewsCnbc-Tv18·14 Aug · 2w ago
1 other SEBI-registered advisor has an active short-term SELL call on this stock
Advisor consensus · same horizon·6 Aug · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.